ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

Paying Attention

Philip Seo, MD, MHS  |  July 18, 2019

I knew I was about to be schooled. That’s what I thought when I first started to read the Twitter feed of Erin D. Michos, MD, MHS, an associate professor of medicine in the Division of Cardiology at Johns Hopkins University, Baltimore. I have a Twitter account, but as a general rule, I use it…

Filed under:OpinionProfessional TopicsRheuminationsSpeak Out Rheum Tagged with:gender balance

CMS 2018 MIPS Performance Feedback, Final Score & Targeted Review Now Available

From the College  |  July 17, 2019

Your 2018 MIPS performance feedback and final score from the CMS are now available on the Quality Payment Program website. To learn more about performance feedback, view the frequently asked questions document from the CMS. The payment adjustment you will receive in 2020 is based on your score for the 2018 performance year. If you…

Filed under:Billing/CodingPractice Support Tagged with:Centers for Medicare & Medicaid Services (CMS)targeted review

White House Scraps Proposal to Lower U.S. Drug Prices

Caroline Humer  |  July 14, 2019

(Reuters)—The Trump administration on Thursday scrapped one of its most ambitious proposals for lowering prescription medicine prices, backing down from a policy that would have required health insurers to pass on billions of dollars in rebates they receive from drugmakers to Medicare patients. The decision represents a new setback to President Donald Trump’s efforts to…

Filed under:Legislation & Advocacy Tagged with:drug pricing blueprintMedicareprescription drug pricesrebate reform initiativerebate ruleTrump administration

Lupus Pregnancy Outcomes Improved Over the Past 2 Decades

Reuters Staff  |  July 9, 2019

NEW YORK (Reuters Health)—Pregnancy outcomes in women with systemic lupus erythematosus (SLE) have improved markedly over the past two decades, although pregnancy risks remain higher than in women without lupus, according to a trends analysis. “Thirty years ago, most women with SLE were advised to avoid pregnancy because of high risks for maternal and fetal…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:mortalitypregnancypregnancy complicationspregnant womenSLEsystemic lupus erythematosus (SLE)

Results for Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

Lara C. Pullen, PhD  |  July 1, 2019

A study of nintedanib in patients with ILD associated with systemic sclerosis showed the treatment had only limited improvement. Although these patients had a lower rate of decline in forced vital capacity than those on placebo, nintedanib did not result in clinical benefits for other manifestations of systemic sclerosis…

Filed under:Conditions

Hot Topics, Fresh Formats: ACR/ARP Annual Meeting Clinical Session Preview

From the College  |  June 26, 2019

The clinical sessions at the 2019 ACR/ARP Annual Meeting feature cutting-edge techniques in rheumatology and enable attendees to hone new skills and explore medically relevant topics…

Filed under:Professional Topics Tagged with:2019 ACR/ARP Annual MeetingClinical

ACR Affiliate Society Council Spotlights State Efforts for Advocacy

Christopher D. Adams, MD, FACP, FACR, and Joseph Cantrell, JD  |  June 19, 2019

So far it has been a busy year for the Affiliate Society Council (ASC). Forty-three states are now affiliated with the ACR through the ASC, and we may add another next year. Also, many state legislative sessions have wrapped up, so it’s a great time to provide an overview of the successes—and some of the…

Filed under:American College of RheumatologyLegislation & Advocacy Tagged with:Affiliate Society Council (ASC)biosimilar legislationbiosimilar substitutionsMedical Association of the State of Alabama (MASA)pharmacy benefit managers (PBMs)state loan forgiveness billstep therapy legislation

Eosinophilic Gastroenteritis & Eosinophilic Ascites Associated with RA

Helen Lyo, Eugene Han, MD, Shivakumar Vignesh, MD, & Nancy Soloman, MD  |  June 17, 2019

Eosinophilic gastroenteritis (EGE) is a rare condition caused by eosinophilic infiltration of the gastrointestinal (GI) tract. The condition is subdivided into the GI layers it affects: mucosal, muscular and subserosal.1 EGE usually presents with non-specific GI symptoms, such as impaired motility, intestinal obstruction and, rarely, ascites.2 Below, we report a rare case of EGE leading…

Filed under:ConditionsRheumatoid Arthritis Tagged with:Eosinophilic AscitesEosinophilic Gastroenteritis

Advocacy Leads to Legislator Access

Paula Marchetta, MD, MBA  |  June 17, 2019

We have often heard it said that opportunity arises from challenges. Challenge, of course, is really just a polite way of saying problem—and for our patients, problems abound when it comes to obtaining timely and affordable access to the rheumatologic care they need. Access in this context has many meanings: There is access to life-changing…

Filed under:Legislation & AdvocacyPresident's Perspective Tagged with:Centers for Medicare & Medicaid Services (CMS)E/M codesRheumPAC

Beyond Addiction: Medical Therapy for Addiction May Benefit Medical Adherence

Thomas R. Collins  |  June 17, 2019

Treating patients with rheumatic disease for their addictions will also encourage patients to address their overall health conditions, resulting in better medical adherence…

Filed under:Conditions Tagged with:Addictionaddiction treatmentOpioid abuseOpioids

  • « Previous Page
  • 1
  • …
  • 44
  • 45
  • 46
  • 47
  • 48
  • …
  • 127
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences